Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy typically begins at a low dose and increases gradually over 16 to 20 weeks, allowing your body to adapt while reducing nausea and gastrointestinal discomfort. This tiered approach, called dose titration, has been shown in clinical trials to improve both safety and weight loss outcomes. PlexusDx offers compounded semaglutide injections through licensed 503A pharmacies, making personalized GLP-1 therapy accessible across all 50 states.
Understanding Semaglutide Dose Titration Schedules
Semaglutide dosing follows a predictable four-step escalation pattern that mirrors the FDA-approved Wegovy protocol. Your treatment typically starts at 0.25 mg once weekly, then increases by 0.25 mg each week until you reach your target maintenance dose. Most patients benefit from doses between 1.0 mg and 2.4 mg weekly, though individual response varies significantly. The entire titration process usually spans 16 to 20 weeks, giving your gastrointestinal system time to adjust and reducing the frequency of side effects like nausea.
This gradual approach differs from jumping directly to higher doses, which can trigger severe stomach discomfort in newly treated patients. Research published in obesity journals demonstrates that slow dose escalation improves medication adherence and reduces discontinuation rates due to side effects. PlexusDx coordinates with you throughout this process, ensuring each dose adjustment aligns with your tolerance and weight loss progress.
The Four-Week Dose Progression Explained
Week one through four brings your first injection at 0.25 mg, the lowest available strength that activates GLP-1 receptors without overwhelming your system. During this phase, many patients experience modest appetite suppression and may notice reduced food cravings, though significant weight loss typically doesn't begin immediately. Your provider monitors your tolerance and adjusts the schedule only if side effects become unmanageable or improvements stall after two weeks. This initial phase establishes your baseline response and confirms that semaglutide is appropriate for your body's unique metabolism.
Weeks five through eight introduce the 0.5 mg dose, doubling the amount from your starting point. At this level, appetite suppression becomes more pronounced, and many patients report eating approximately 30% less than their baseline intake. The risk of gastrointestinal side effects increases slightly, but most people tolerate this dose without difficulty. Staying hydrated and eating nutrient-dense, smaller meals during this phase supports both tolerability and continued weight loss momentum.
Maintenance Doses and Long-Term Weight Loss Results
Once your body reaches the 2.4 mg maintenance dose—typically after four months of treatment—most clinical benefit emerges. At this therapeutic level, patients in randomized controlled trials lost an average of 15% to 22% of their body weight over 68 weeks, with some achieving reductions exceeding 25%. Maintenance dosing remains consistent week to week; you inject the same 2.4 mg amount every seven days unless your provider recommends adjustments based on your response. Some patients plateau at lower effective doses like 1.7 mg or 2.0 mg, achieving their weight loss goals without advancing further.
PlexusDx ensures your maintenance dose aligns with your treatment goals and current health status. The Precision Peptide Genetic Test can identify whether variants in your GLP1R gene (rs6923761) or GIPR gene (rs1800437) affect how efficiently your body responds to semaglutide at standard doses. This genetic insight helps your provider determine whether you may benefit from staying at a lower effective dose or advancing more aggressively toward the 2.4 mg maximum.
Flexible Dosing and Individual Response Patterns
Not every patient follows the exact four-step progression outlined in standard protocols. Some individuals experience robust appetite suppression at 0.5 mg and pause advancement there, achieving their weight loss target without higher doses. Others require reaching 2.4 mg to see meaningful results, particularly if they carry genetic variants affecting peptide sensitivity. Your healthcare provider may recommend staying at an intermediate dose like 1.7 mg if you're losing weight steadily and tolerating the medication well. This flexibility means your treatment plan remains truly personalized, not rigidly locked into a one-size-fits-all approach.
Side effect management also influences dosing decisions. If nausea or stomach discomfort becomes severe at a particular level, your provider may extend the time spent at that dose before advancing, or suggest temporary reductions followed by slower re-escalation. PlexusDx provides access to clinical support throughout your journey, ensuring your dose adjustments happen on a timeline that works for your body and lifestyle. Cost remains constant regardless of your dose level—your monthly investment in treatment reflects your commitment tier, not the strength of your injection.
How PlexusDx Pricing Differs From Dose-Based Models
Traditional weight loss clinics often structure pricing around dose levels, charging more as your semaglutide strength increases from 0.25 mg to 2.4 mg. PlexusDx operates on a fundamentally different model: your monthly price remains flat regardless of whether you inject 0.25 mg or 2.4 mg. Compounded semaglutide injections start at $149 monthly across your entire treatment journey, whether you're in the titration phase or stabilized at maintenance. This transparent pricing eliminates surprise cost increases when your provider advances your dose, removing a significant barrier to optimal treatment.
PlexusDx also accepts HSA and FSA funds, making medication costs even more accessible for eligible patients. No insurance is required, and there's no membership fee—your monthly rate covers the medication itself, prepared by licensed 503A compounding pharmacies serving all 50 states. When you're ready to explore whether genetic factors affect your semaglutide response, the Precision Peptide Genetic Test costs just $99 after your first month of treatment, offering insights into 14 metabolic pathways and 150+ peptide-related factors.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide, and how quickly does it increase?
Semaglutide treatment begins at 0.25 mg once weekly, increasing by 0.25 mg each week until you reach your target maintenance dose—typically 2.4 mg or lower if you achieve your goals sooner. The entire progression usually takes 16 to 20 weeks. PlexusDx coordinates dose adjustments based on your tolerance and weight loss response, with your monthly price remaining constant at $149 regardless of dose level.
Why does semaglutide use a gradual dose escalation instead of starting at the full dose?
Gradual titration significantly reduces severe gastrointestinal side effects like nausea and vomiting while improving treatment adherence and long-term success rates. Clinical trials show that patients tolerate slow escalation better and are more likely to continue treatment long-term compared to those starting at higher doses immediately. This approach also allows your body's GLP-1 receptors to become sensitized gradually, maximizing appetite suppression at each level.
Can I stop my dose increase if I'm already losing weight at a lower level?
Yes—if you're achieving meaningful weight loss at 0.5 mg, 1.0 mg, 1.7 mg, or any intermediate dose, your provider can keep you at that level indefinitely. PlexusDx supports flexible dosing based on your individual results and tolerance, not a rigid protocol. Many patients reach their target weight without advancing to the maximum 2.4 mg dose.
What happens if I experience severe side effects at a particular dose?
Your PlexusDx provider can extend the time at your current dose, temporarily reduce your injection strength, or slow your progression to the next level. Managing side effects is a core part of treatment planning; nausea and stomach discomfort often improve within days to weeks as your body adapts. Staying hydrated, eating smaller meals, and avoiding high-fat foods accelerates tolerance in most cases.
How does the Precision Peptide Genetic Test help with dose planning?
The test identifies variants in your GLP1R and GIPR genes that influence how efficiently semaglutide activates your appetite-suppression pathways. Patients with certain genetic profiles may respond robustly at lower doses, while others benefit from advancing more confidently toward higher therapeutic levels. This $99 test, available after your first month of treatment, maps 14 metabolic pathways and 150+ genetic insights to personalize your dosing strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Do You Lose on 0.5 Wegovy?
How to Prevent Side Effects from Wegovy: A Comprehensive Guide